UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-----------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) SEPTEMBER 30, 2004
------------------
HYDRON TECHNOLOGIES, INC.
----------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
NEW YORK 0-6333 13-1574215
--------------------------------------------------------------------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) file number) Identification number)
2201 WEST SAMPLE ROAD, BUILDING 9, SUITE 7B, POMPANO BEACH, FL 33073
------------------------------------------------------------------------
(Address of principal executive offices, including zip code)
Registrant's telephone number, including area code (954) 861 6400
NOT APPLICABLE
------------------------------------------------------------------------
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrants under any of the
following provisions (see General Instruction A.2. below):
[ ] Written Communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
ITEM 8.01. OTHER EVENTS
Hydron Technologies, Inc. (Hydron), as general partner, has formed
Hydron Royalty Partners, LLLP (Partners), a Limited Liability Limited
Partnership for the purpose of funding existing royalty obligations and
a portion of future royalty obligations in consideration of sharing
future royalty income that may arise from Hydron's agreement with Valera
Pharmaceuticals, Inc. (Valera). Partners has completed a non-brokered
private placement of Limited Partnership Interest to ten accredited
investors including Hydron's Chairman, Richard Banakus and a Hydron
Director, Ronald J. Saul. Each limited partner invested $30,000 or an
aggregate of $300,000 for a 49.999% interest of Partners.
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
HYDRON TECHNOLOGIES, INC.
/s/: William A. Lauby
--------------------------
William A. Lauby
Chief Financial Officer
Dated: October 1, 2004
Exhibit Index
Exhibit No. Description
----------- -----------
99(i) Specimen of Partnership Agreement